Healthline: Controversial studies find COVID-19 may be far more widespread than previously known

UC expert says lack of testing could be a factor

Healthline interviewed Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases for a news story on two studies in California finding that COVID-19 may be much more widespread than previously thought.

Dr. Fichtenbaum and Jassiel HIV study in lab.

Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases. Photo/Colleen Kelley/UC Creative + Brand

Fichtenbaum said one of the reasons for the discrepancy was a lack of testing. 

“Because testing for the virus is not widely available due to lack of supplies, reagents, and machines, it’s not surprising that a sero-epidemiologic survey would find more individuals with infection,” Fichtenbaum said.

Read the entire article here

Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.

Related Stories

1

6 ways starting a GLP-1 medication could affect your emotions

May 20, 2026

When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.

3

$15 million bequest supports endowed chair at UC College of Medicine

May 19, 2026

As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.